About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | High Dose BAYA1040_Nifedipine: a Dose-comparative Study

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

NCT01287260·22 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bayer

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

20 years or older
Japanese male or female
Outpatient with essential hypertension
Patients whose sitting diastolic blood pressure (DBP) is 90 mmHg or more despite more than 4 weeks of treatment with antihypertensive drug

You may not be if

Sitting diastolic blood pressure (DBP) is 110 mmHg or more or sitting systolic blood pressure (SBP) is 180 mmHg or more
Patients with secondary hypertension or hypertensive emergency

The record

StatusCompleted

PhasePhase 3

Taking part352

StartedJan 2011

UpdatedJan 29, 2014

Conditions

Where22

Hirosaki, Aomori, Japan
Kamagaya, Chiba, Japan
Asahikawa, Hokkaido, Japan